February 22, 2017
Just got a text from my coordinator to inform me that the keytruda (immunotherapy) drug has some new safety warnings. Apparently, taking the drug can lead to Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis (that's not a pretty thing) and immune mediated myocarditis.
I'm pretty sure the myocarditis warning is due to 2 Optiva patients that died following their initial treatment with that drug, and given Keytruda is also a cancer immunotherapy drug the warning was added to it as well.
I'll continue on with the trial even with these new potential side-effects, because ultimately I figure it is worth the risk. Plus most of these new problems are reported about 14 days after the first dose, and I'll be having my 7th in a couple of weeks. Just one more thing that I need to pray about...
|